Reported Jan 6, 2021 · Terminated
NDC 64380-721-06 TACROLIMUS CAPSULES, USP 1mg 100 Capsules Rx Only Manufactured by: Strides Pharma Science Ltd.…
Strides Pharma Inc.
Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Strides Pharma Inc. · 2 Tower Center Blvd Ste 1102 · East Brunswick, NJ · 08816-1100
Is this the product you have?
NDC 64380-721-06 TACROLIMUS CAPSULESUSP 1mg 100
- Capsules Rx Only Manufactured byStrides Pharma Science Ltd. Bengaluru - 562106
- India Distributed byStrides Pharma Inc. East Brunswick, NJ 08816
- Lot codes and dates
Lot 7242728AJune 2023
- Amount recalled
- 960 bottles
Where it was sold
Why it was recalled
Failed Moisture Limits
This product is unlikely to cause harm, but it breaks a safety or labelling rule.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Strides Pharma Inc. recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.